What is the recommended treatment and dosage for H. pylori (Helicobacter pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment and Dosage for Helicobacter pylori Infection

The first-line treatment for H. pylori infection should be a 14-day bismuth-containing quadruple therapy, especially in areas with high clarithromycin resistance (≥15%). 1, 2

First-Line Treatment Options

In Areas with High Clarithromycin Resistance (≥15%):

  • Bismuth quadruple therapy for 14 days: 1, 2
    • PPI (proton pump inhibitor) twice daily
    • Bismuth subsalicylate/subcitrate four times daily
    • Metronidazole 500 mg three or four times daily
    • Tetracycline 500 mg four times daily

In Areas with Low Clarithromycin Resistance (<15%):

  • Triple therapy for 14 days: 1, 2

    • PPI twice daily
    • Clarithromycin 500 mg twice daily
    • Amoxicillin 1 g twice daily
  • Alternative: Sequential therapy (10-14 days): 1

    • First 5 days: PPI + amoxicillin
    • Next 5-9 days: PPI + clarithromycin + metronidazole

Optimizing Treatment Efficacy

  • Use high-dose PPI (twice daily) to increase treatment efficacy by 6-10% 1, 2
  • Preferred PPIs: 40 mg esomeprazole or rabeprazole twice daily (more potent than omeprazole) 1
  • Extend treatment duration to 14 days to improve eradication rates by approximately 5% 1, 2
  • Consider probiotics as adjuvant treatment to reduce side effects 1, 2

Second-Line Treatment Options

After failure of first-line therapy, choose a regimen that avoids previously used antibiotics: 2, 3

  • If clarithromycin-based therapy failed:

    • Bismuth quadruple therapy (if not used previously) for 14 days 1, 2
    • Levofloxacin-based triple therapy for 14 days: 1, 2
      • PPI twice daily
      • Amoxicillin 1 g twice daily
      • Levofloxacin 500 mg once daily or 250 mg twice daily
  • If bismuth quadruple therapy failed:

    • Levofloxacin-based triple therapy for 14 days 1, 2
    • Rifabutin triple therapy for 14 days: 1
      • Rifabutin 150 mg twice daily
      • Amoxicillin 1 g three times daily
      • PPI (esomeprazole or rabeprazole 40 mg) twice daily

Third-Line Treatment

  • After two treatment failures, antimicrobial susceptibility testing should guide therapy whenever possible 1, 2
  • If testing is unavailable, use antibiotics not previously used 4

Special Considerations

For Patients with Penicillin Allergy:

  • In areas of low clarithromycin resistance: 1
    • PPI + clarithromycin + metronidazole
  • In areas of high clarithromycin resistance: 1
    • Bismuth-containing quadruple therapy

FDA-Approved Regimens (per Amoxicillin Label):

  • Triple therapy: 5
    • Amoxicillin 1 g twice daily
    • Clarithromycin 500 mg twice daily
    • Lansoprazole 30 mg twice daily
    • Duration: 14 days
  • Dual therapy: 5
    • Amoxicillin 1 g three times daily
    • Lansoprazole 30 mg three times daily
    • Duration: 14 days

Confirmation of Eradication

  • Perform urea breath test or monoclonal stool antigen test at least 4 weeks after completing treatment 1, 2
  • Serology should not be used to confirm eradication 1, 2

Common Pitfalls to Avoid

  • Using clarithromycin-based therapy in areas with >15% resistance rates leads to treatment failure 1, 3
  • Using standard-dose PPI instead of high-dose reduces efficacy 1
  • Treating for less than 14 days decreases eradication rates 1, 2
  • Failing to test for eradication after treatment 1, 2
  • Using previously failed antibiotics in rescue regimens 1, 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Helicobacter Pylori Eradication Regimens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

The American journal of gastroenterology, 2024

Research

Management of Helicobacter pylori infection.

JGH open : an open access journal of gastroenterology and hepatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.